Cystadane
betaine anhydrous
Betaine anhydrous
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or your pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet. See section 4.
What Cystadane is and what it is used for
What do you need to know before you take Cystadane
How to take Cystadane
Possible side effects
5 How to store Cystadane
6. Contents of the pack and other information
Cystadane contains betaine anhydrous which is intended to be an adjunctive treatment of homocystinuria, an inherited (genetic) disease where the amino acid methionine cannot be broken down completely by the body.
Methionine is present in regular food protein (e.g. meat, fish, milk, cheese, eggs). It is converted into homocysteine which is then normally converted into cysteine during digestion. Homocystinuria is a disease caused by the accumulation of homocysteine which is not converted to cysteine and is characterised by formation of clots in the veins, bone weakness, and skeletal and crystalline lens abnormalities. The use of Cystadane together with other treatments such as vitamin B6, vitamin B12, folate and a specific diet aims to reduce the elevated homocysteine levels in your body.
If you are allergic to betaine anhydrous.
Talk to your doctor or pharmacist before taking Cystadane.
If you notice side effects like headaches, vomiting or a change in your vision and you are of the homocystinuria subtype called CBS (cystathionine beta-synthase deficiency), please contact your doctor immediately, they could be signs of a swelling in the brain (cerebral oedema). In that case your doctor will monitor your methionine level in your body and may review your diet. Your treatment with Cystadane may need to be interrupted.
If you are treated with Cystadane and with an amino-acid mixture and if you need to take other medicines at the same time, leave 30 minutes between the intake (see “section “Other medicines and Cystadane”).
Tell your doctor if you are taking, have recently taken or might take any other medicines.
If you are taking amino-acid mixture or medicines such as vigabatrin or Gaba analogues (medicine used to treat epilepsy), please tell your doctor as they might interact with your treatment with
Cystadane.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask
your doctor for advice before taking this medicine. Your doctor will decide if you can use this medicine during pregnancy and breast-feeding.
Cystadane has no or negligible influence on the ability to drive and use machines.
The use of this medicine will be supervised by a doctor experienced in the treatment of patients with homocystinuria.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose in children and adults is 100mg/kg/day divided in 2 dosesper day. In some patients doses above 200 mg/ kg/day were needed to reach therapeutic goals. Your doctor may adapt the dose depending on your laboratory values.
You will therefore need regular blood tests to determine the correct daily dose. You should take Cystadane orally (by mouth).
To measure the dose:
shake the bottle lightly before opening
take the correct measuring spoon:
the small green spoon measures 100 mg of betaine anhydrous powder;
the middle size blue spoon measures 150 mg of betaine anhydrous powder ;
the large pink spoon measures 1 g of betaine anhydrous powder.
take a heaped spoonful of powder out of the bottle
pass the flat back of a knife over the top of the spoon
the powder left in the spoon is one spoonful
take the correct number of spoonfuls of powder from the bottle
Mix the measured dose of powder with water, juice, milk, formula or food until completely dissolved and ingest immediately after mixing.
If you accidentally take too much Cystadane, talk to a doctor or pharmacist immediately.
Do not take a double dose to make up for forgotten doses. If you forget to take a dose take it as soon as
you remember it and continue the next dose as planned.
Do not stop the treatment without consulting your doctor. Contact your doctor or pharmacist before stopping.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most commonly side effect when taking Cystadane which may affect more than 1 in 10 people (frequency very common) is elevated levels of methionine in the blood.
Methionine level can be related to swelling in the brain (cerebral swelling), which may affect up to 1 in 100 people (frequency uncommon). If you experience morning headaches with vomiting and/or
visual changes, contact immediately your doctor (they could be signs of a swelling in the brain).
Gastrointestinal disorders like diarrhoea, nausea, vomiting, stomach discomfort and inflammation of the tongue may occur uncommonly (may affect up to 1 in 100 people).
Other uncommon side effects (may affect up to 1 in 100 people) may include decreased appetite
(anorexia), agitation, irritability, hair loss, hives, skin odour abnormal, lack of control over passing urine (urinary incontinence).
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the bottle label and the carton after EXP. The expiry date refers to the last day of that month.
Do not store above 25C.
Keep the bottle tightly closed in order to protect from moisture.
After the first opening of the bottle, the medicine should be used within 3 months.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is betaine anhydrous. 1 g of oral powder contains 1 g of betaine anhydrous.
There is no other ingredient.
Cystadane is a white crystalline free flowing powder. It is presented in bottles with child resistant closures. Each bottle contains 180 g of powder. Each carton contains one bottle and three measuring spoons.
70, avenue du General de Gaulle F-92 800 Puteaux
France
70, avenue du Général de Gaulle
F-92800 Puteaux France
or
Recordati Rare Diseases Eco River Parc
30, rue des Peupliers
F-92000 Nanterre France
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.
Recordati
Tél/Tel: +32 2 46101 36
Belgique
Recordati AB.
Tel: + 46 8 545 80 230
Švedija
Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58
Франция
Recordati
Tél/Tel: +32 2 46101 36
Belgique/Belgien
Francie
Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58
Franciaország
Recordati AB.
Tlf : +46 8 545 80 230
Sverige
Recordati Rare Diseases Tel: +33 1 47 73 64 58
Franza
Recordati Rare Diseases Germany GmbH Tel: +49 731 140 554 0
Recordati
Tel: +32 2 46101 36
België
Recordati AB.
Tel: + 46 8 545 80 230
Rootsi
Recordati AB.
Tlf : +46 8 545 80 230
Sverige
Recordati Rare Diseases Τηλ: +33 (0)1 47 73 64 58
Γαλλία
Recordati Rare Diseases Germany GmbH Tel: +49 731 140 554 0
Deutschland
Recordati Rare Diseases Spain S.L.U. Tel: + 34 91 659 28 90
Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58
Francja
Recordati Rare Diseases Tél: +33 (0)1 47 73 64 58
Jaba Recordati S.A. Tel: +351 21 432 95 00
Recordati Rare Diseases Tél: +33 (0)1 47 73 64 58
Francuska
Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58
Franţa
Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58
France
Recordati Rare Diseases Tel: +33 (0)1 47 73 64 58
Francija
Recordati AB. Simi:+46 8 545 80 230
Svíþjóð
Francúzsko
Recordati Rare Diseases Italy Srl Tel: +39 02 487 87 173
Recordati AB.
Puh/Tel : +46 8 545 80 230
Sverige
Recordati Rare Diseases Τηλ : +33 1 47 73 64 58
Γαλλία
Recordati AB.
Tel : +46 8 545 80 230
Recordati AB.
Tel: + 46 8 545 80 230
Zviedrija
Recordati Rare Diseases UK Ltd. Tel: +44 (0)1491 414333
. There are also links to other websites about rare diseases and treatments.